Dr. Dunsmore is a program director in the NIGMS Division of Pharmacology, Physiology, and Biological Chemistry, where she oversees research grants in the areas of receptors, drug targets and signal transduction; sepsis and innate immunity; and inflammation. She serves as the program director for several clinical trials testing novel treatments for sepsis and septic shock.
Prior to joining NIGMS in 2006, Dunsmore was a faculty member at Harvard Medical School and conducted pulmonary research in a laboratory based at Brigham and Women’s Hospital in Boston, MA.
To arrange an interview with Sarah Dunsmore, contact the NIGMS Office of Communications and Public Liaison at 301-496-7301.
Watch Sarah Dunsmore talk about sepsis.